FDA
approval
· 2019-10-09
FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
Summary
FDA approved a supplemental application for Sun Pharmaceutical Industries' buprenorphine and naloxone product. This action grants regulatory approval of a suppl…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)